| 3-D Vision - American Optometric Assoc. - Video 3-D TV and Movies Look to Attract Viewers But Not Everyone Can ‘See’ What All the Hype is About feedproxy.google.com |
Enzo Biochem takes bigger 3Q loss as costs grow (AP) Biotechnology company Enzo Biochem Inc. said Wednesday that its third-quarter loss grew as it spent more in the period this year than last. us.rd.yahoo.com |
NPS Pharmaceuticals, Inc. Q2 2010 Earnings Conference Call Transcript NPS Pharmaceuticals, Inc. Q2 2010 Earnings Conference Call August 4, 2010 17:00 E.TComplete Story » seekingalpha.com |
Interview: Cleveland BioLabs CEO Discusses Recent Developments, Milestones Ahead M.E. Garza submits: We are hearing some very loud and credible chatter that long-awaited good news may be coming for Cleveland BioLabs (CBLI), the company that engages in the discovery, development, and commercialization of products for human protection from radiation.In the first quarter of this year, the company submitted additional paperwork about Protectan CBLB502 (a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy) to a potential customer - the U.S. Government's Department of Defense. Many on Wall Street believe that the company has the best chance of not only getting significant funding from the DoD, but also a potentially bigger order from the Biomedical Advanced Research and Development Authority (BARDA) who would acquire doses of the drug for the Strategic National Stockpile.Complete Story » seekingalpha.com |
Zimmer Holdings: Nothing to Get Excited About Margin of Safety Investing submits: Zimmer Holdings (ZMH) is a leader in knee and hip implants and plays in a number of other orthopedic niches. The company was added to the idea pipeline as Morningstar rates it a 5-star wide moat company. ZMH’s stock is currently trading at $51-52. 1- Business Performance Risk (=) and intrinsic returns (=)Complete Story » seekingalpha.com |